Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Craigavon-based pharmaceutical development company Almac recorded pre-tax profits of £19.2m in 2013, up around 30% on the previous year, it has announced.
read more
As the Industry faces the tightest ever new heavy metal mandates from the FDA, stipulating the control and documentation, where appropriate, of all elemental impurities in drug products, drug substances and excipients, Almac has invested in state of ...
read more
Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following ...
read more
Friday, December 13, 2013
Almac‘s Enzyme Research and Development team have been recognised at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
read more
The Almac Group Ltd, Is pleased to announce plans to make its ALM AADx assay – a gene expression test developed by its Diagnostics Business Unit – available for clinical use in 2015. Further validation of the test in ovarian cancer is on track for ...
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
Alphora is pleased to announce that it has added GMP ICP/MS Heavy Metals Testing in-house, to align with the increased regulatory requirements of USP <232> & <233>, which became effective February 1, 2013. API Drug Substances, Drug Products and Excipients will...
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
Wednesday, November 18, 2015
Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion.
read more
Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea’s Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton ...
read more
Wednesday, October 24, 2018
Bazelet signed a manufacturing and licensing agreement with Israeli medical cannabis pharmaceutical product developer Alvit LCS Pharma.
read more
Monday, November 11, 2019
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup 150 mg/10 mL Liquid Unit Dose Cups to the consumer level.
read more
Wednesday, December 06, 2017
Carmot and Amgen will work to select therapeutic targets and identify drug candidates.
read more
Monday, November 12, 2012
AminoAcids.com is proud to announce the release of our newly validated B Vitamin Panel Analysis including Folic Acid for fresh/spent cell culture and fermentation media.
read more
Wednesday, November 13, 2019
Amneal Pharmaceuticals is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level.
read more